Pharmaco économie des stratégies thérapeutiques de la maladie de Crohn active Analyse coût-utilité de l'Infliximab vs adalimumab.
Year: 2019
Type: article
Authors: H Benbachir, S Guellil, Y El Mir, Houari Toumi
Institution: Université Oran 1 Ahmed Ben Bella
Language: French
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3086985488